Skip Navigation LinksVaccine Adverse Event Reporting System. The image includes photgraphs of a couple, a doctor, a women and child, a baby, and an elderly.
     

CDC

Food and Drug Administration (FDA)

Introduction

Frequently Asked Questions

Bibliography

Contact Information

VAERS Form
(PDF 23K)

VAERS Web Submission

VAERS Data

VAERS Continuing Education

Publications

Links

Privacy Policies & Disclaimers

Call VAERS at
1-800-822-7967

VAERS Bibliography - July 2003

  1. Proceedings of the Scientific Symposium on Vaccination Against Influenza. Kemi, Finland. March 22, 2002.  Vaccine.  20 (Suppl. 5): B1-54; December 2002.

  2. Update: Adverse Events Following Civilian Smallpox Vaccination--United States, 2003.  MMWR Morb.Mortal.Wkly.Rep.  52 (20): 475-477; May 23, 2003.

  3. Update: Adverse Events Following Civilian Smallpox Vaccination--United States, 2003.  MMWR Morb.Mortal.Wkly.Rep.  52 (19): 444-446; May 16, 2003.

  4. Update: Influenza Activity--United States and Worldwide, 2002-03 Season, and Composition of the 2003-04 Influenza Vaccine.  MMWR Morb.Mortal.Wkly.Rep.  52 (22): 516-521; June 6, 2003.

  5. Vaccine-Preventable Diseases and Vaccination Coverage in Australia, 1999-2000.  N.S W.Public Health Bull.  14 (4-5): 94; April 2003.

  6. When to Vaccinate Travellers Against Meningococci.   Prescrire.Int.  12 (65): 109-110; June 2003.

  7. ACOG Committee Opinion. Number 281, December 2002. Rubella Vaccination.   Int J Gynaecol.Obstet.  81 (2): 241; May 2003.

  8. Update: Adverse Events Following Civilian Smallpox Vaccination--United States, 2003.   MMWR Morb.Mortal.Wkly.Rep.  52 (18): 419-420; May 9, 2003.

  9. Update: Cardiac-Related Events During the Civilian Smallpox Vaccination Program--United States, 2003.  MMWR Morb.Mortal.Wkly.Rep.  52 (21): 492-496; May 30, 2003.

  10. Smallpox Vaccination for Emergency Physicians.  Acad.Emerg.Med.  10 (6): 681-683; June 2003.

  11. States Suspend Vaccinations in Wake of Deaths.  Revolution.  4 (2): 8; March 2003.

  12. Update: Smallpox Vaccination Program.   Tex.Nurs.  77 (3): 11, 14; March 2003.

  13. Abramson, J. S.; McMillan, J. A.; Baltimore, R. S.  The US Smallpox Vaccination Plan.  Pediatrics.  111 (6 Pt 1): 1431-1432; June 2003.

  14. Ada, G.  Progress Towards Achieving New Vaccine and Vaccination Goals.  Intern.Med.J.  33 (7): 297-304; July 2003.

  15. Arya, S. C.  Smallpox Vaccination to Combat Bioterrorism.  Clin.Infect.Dis.  37 (1): 150-151; July 1, 2003.

  16. Bager, P.; Westergaard, T.; Rostgaard, K.; Nielsen, N. M.; Melbye, M.; Aaby, P.  Smallpox Vaccination and Risk of Allergy and Asthma.  J Allergy Clin.Immunol.  111 (6): 1227-1231; June 2003.

  17. Bidat, E.; Rance, F.; Gaudelus, J.  [Vaccination in Children With Egg Allergy].  Arch.Pediatr.  10 (3): 251-253; March 2003.

  18. Bridges, M. J.; Coady, D.; Kelly, C. A.; Hamilton, J.; Heycock, C.  Factors Influencing Uptake of Influenza Vaccination in Patients With Rheumatoid Arthritis.  Ann.Rheum.Dis.  62 (7): 685; July 2003.

  19. Brotherton, J.; McAnulty, J.  A Pertussis Epidemic in NSW: How Epidemiology Reflects Vaccination Policy.  N.S W.Public Health Bull.  14 (4-5): 77-81; April 2003.

  20. Brydak, L. B.; Machala, M.; Mysliwska, J.; Mysliwski, A.; Trzonkowski, P.  Immune Response to Influenza Vaccination in an Elderly Population.  J Clin.Immunol.  23 (3): 214-222; May 2003.

  21. Cherry, J. D.  Risks to Children of Health Care Personnel Receiving Smallpox Vaccination.  Pediatr.Infect.Dis J.  22 (6): 574-575; June 2003.

  22. Chu, N. R.  Therapeutic Vaccination for the Treatment of Mucosotropic Human Papillomavirus-Associated Disease.  Expert.Opin.Biol.Ther.  3 (3): 477-486; June 2003.

  23. Classen, J. B.; Classen, D. C.  Clustering of Cases of Type 1 Diabetes Mellitus Occurring 2-4 Years After Vaccination Is Consistent With Clustering After Infections and Progression to Type 1 Diabetes Mellitus in Autoantibody Positive Individuals.  J Pediatr.Endocrinol.Metab.  16 (4): 495-508; April 2003.

  24. Clements, C.  Mass Psychogenic Illness After Vaccination.  Drug Saf.  26 (9): 599-604; 2003.

  25. Dhiman, N.; Ovsyannikova, I. G.; Pinsky, N. A.; Vierkant, R. A.; Jacobsen, S. J.; Jacobson, R. M.; Poland, G. A.  Lack of Association Between Transporter Associated With Antigen Processing (TAP) and HLA-DM Gene Polymorphisms and Antibody Levels Following Measles Vaccination.  Eur.J Immunogenet.  30 (3): 195-200; June 2003.

  26. Eilertson, L.  Vaccination Available.  Nurs.Manage.  34 (6): 9; June 2003.

  27. Enquselassie, F.; Ayele, W.; Dejene, A.; Messele, T.; Abebe, A.; Cutts, F. T.; Nokes, D. J.  Seroepidemiology of Measles in Addis Ababa, Ethiopia: Implications for Control Through Vaccination.  Epidemiol.Infect.  130 (3): 507-519; June 2003.

  28. Esposito, S.; Marchisio, P.; Cavagna, R.; Gironi, S.; Bosis, S.; Lambertini, L.; Droghetti, R.; Principi, N.  Effectiveness of Influenza Vaccination of Children With Recurrent Respiratory Tract Infections in Reducing Respiratory-Related Morbidity Within the Households.  Vaccine.  21 (23): 3162-3168; July 4, 2003.

  29. Everett, W. W.; Coffin, S. E.; Zaoutis, T.; Halpern, S. D.; Strom, B. L.  Smallpox Vaccination: a National Survey of Emergency Health Care Providers.  Acad.Emerg.Med.  10 (6): 606-611; June 2003.

  30. Fedson, D. S.  Vaccination for Pandemic Influenza and Severe Acute Respiratory Syndrome: Common Issues and Concerns.  Clin.Infect.Dis.  36 (12): 1562-1563; June 15, 2003.

  31. Fishman, J. A.  Smallpox and Live-Virus Vaccination in Transplant Recipients.  Am.J Transplant.  3 (7): 786-793; July 2003.

  32. Frey, C. R.; Sharp, M. A.; Min, A. S.; Schmid, D. S.; Loparev, V.; Arvin, A. M.  Identification of CD8+ T Cell Epitopes in the Immediate Early 62 Protein (IE62) of Varicella-Zoster Virus, and Evaluation of Frequency of CD8+ T Cell Response to IE62, by Use of IE62 Peptides After Varicella Vaccination.  J Infect.Dis.  188 (1): 40-52; July 1, 2003.

  33. Garcia-Lora, A.; Algarra, I.; Collado, A.; Garrido, F.  Tumour Immunology, Vaccination and Escape Strategies.  Eur.J Immunogenet.  30 (3): 177-183; June 2003.

  34. Givon-Lavi, N.; Fraser, D.; Dagan, R.  Vaccination of Day-Care Center Attendees Reduces Carriage of Streptococcus Pneumoniae Among Their Younger Siblings.  Pediatr.Infect.Dis J.  22 (6): 524-532; June 2003.

  35. Grabenstein, J. D.; Winkenwerder, W., Jr.  US Military Smallpox Vaccination Program Experience.  JAMA.  289 (24): 3278-3282; June 25, 2003.

  36. Halsell, J. S.; Riddle, J. R.; Atwood, J. E.; Gardner, P.; Shope, R.; Poland, G. A.; Gray, G. C.; Ostroff, S.; Eckart, R. E.; Hospenthal, D. R.; Gibson, R. L.; Grabenstein, J. D.; Arness, M. K.; Tornberg, D. N.  Myopericarditis Following Smallpox Vaccination Among Vaccinia-Naive US Military Personnel.  JAMA.  289 (24): 3283-3289; June 25, 2003.

  37. Harmanci, H.; Gurbuz, Y.; Torun, S. D.; Tumerdem, N.; Erturk, T.  Reasons for Non-Vaccination During National Immunization Days: a Case Study in Istanbul, Turkey.  Public Health.  117 (1): 54-61; January 2003.

  38. Holt, P. G.  Functionally Mature Virus-Specific CD8(+) T Memory Cells in Congenitally Infected Newborns: Proof of Principle for Neonatal Vaccination?   J Clin.Invest.  111 (11): 1645-1647; June 2003.

  39. Howard-Ruben, J.  Ongoing Debate Over Smallpox Vaccinations Continues.  ONS.News.  18 (6): 12, 16; June 2003.

  40. Iyngkaran, P.; Limaye, V.; Hill, C.; Henderson, D.; Pile, K. D.; Rischmueller, M.  Rheumatoid Vasculitis Following Influenza Vaccination.  Rheumatology.(Oxford).  42 (7): 907-909; July 2003.

  41. Jautova, J.; Dorko, E.; Pilipcinec, E.; Tkacikova, L.  Effect of Vaccination Therapy for Acne, Using a Staphylococci Antigenic Complex in Combination With Clindamycin.  Folia Microbiol.(Praha).  48 (2): 249-252; 2003.

  42. Jessop, A. B.; Hausman, A. J.  Pneumococcal Vaccination in Pennsylvania Nursing Homes: Factors Associated With Vaccination Level.  J Am.Med.Dir.Assoc.  3 (6): 347-351; November 2002.

  43. Kang, N. G.; Oh, C. W.  Gianotti-Crosti Syndrome Following Japanese Encephalitis Vaccination.  J Korean Med.Sci.  18 (3): 459-461; June 2003.

  44. Kwon, N.; Raven, M. C.; Chiang, W. K.; Moran, G. J.; Jui, J.; Carter, R. A.; Goldfrank, L.  Emergency Physicians' Perspectives on Smallpox Vaccination.  Acad.Emerg.Med.  10 (6): 599-605; June 2003.

  45. Moorhouse, M.  Smallpox Vaccination Program Update: April 2003.  Colo.Nurse.  103 (2): 21; June 2003.

  46. Nace, D. A.  Improving Pneumococcal Vaccination Rates.  J Am.Med.Dir.Assoc.  4 (2): 121-122; March 2003.

  47. Parmiani, G.; Pilla, L.; Castelli, C.; Rivoltini, L.  Vaccination of Patients With Solid Tumours.  Ann.Oncol.  14 (6): 817-824; June 2003.

  48. Pennachio, D.; Terry, K.  Have You Been Vaccinated?   Med.Econ.  80 (8): 57-60, 66; April 25, 2003.

  49. Sarria-Santamera, A.; Timoner, J.  Influenza Vaccination in Old Adults in Spain.  Eur.J Public Health.  13 (2): 133-137; June 2003.

  50. Sauerbrei, A.; Uebe, B.; Wutzler, P.  Molecular Diagnosis of Zoster Post Varicella Vaccination.  J Clin.Virol.  27 (2): 190-199; July 2003.

  51. Saurina, G.; Shirazi, S.; Lane, J. M.; Daniel, B.; DiEugenia, L.  Myocarditis After Smallpox Vaccination: a Case Report.  Clin.Infect.Dis.  37 (1): 145-146; July 1, 2003.

  52. Shaikh, I.; Omair, A.; Inam, S. N.; Safdar, S.; Kazmi, T.; Anjum, Q.  National Polio Day Campaign in a Squatter Settlement Through Medical Students.  J Pak.Med.Assoc.  53 (3): 98-101; March 2003.

  53. Sisk, J. E.; Whang, W.; Butler, J. C.; Sneller, V. P.; Whitney, C. G.  Cost-Effectiveness of Vaccination Against Invasive Pneumococcal Disease Among People 50 Through 64 Years of Age: Role of Comorbid Conditions and Race.  Ann.Intern.Med.  138 (12): 960-968; June 17, 2003.

  54. Smith, D. J.; Bot, S.; Dellamary, L.; Bot, A.  Evaluation of Novel Aerosol Formulations Designed for Mucosal Vaccination Against Influenza Virus.  Vaccine.  21 (21-22): 2805-2812; June 20, 2003.

  55. Straetemans, M.; Sanders, E. A.; Veenhoven, R. H.; Schilder, A. G.; Damoiseaux, R. A.; Zielhuis, G. A.  Review of Randomized Controlled Trials on Pneumococcal Vaccination for Prevention of Otitis Media.  Pediatr.Infect.Dis J.  22 (6): 515-524; June 2003.

  56. Talbot, T. R.; Bredenberg, H. K.; Smith, M.; LaFleur, B. J.; Boyd, A.; Edwards, K. M.  Focal and Generalized Folliculitis Following Smallpox Vaccination Among Vaccinia-Naive Recipients.  JAMA.  289 (24): 3290-3294; June 25, 2003.

  57. Trossman, S.  The Return of the Smallpox Vaccination. Nurses Report on Plans, Concerns.  Am.Nurse.  35 (2): 1-2, 12; March 2003.

  58. Tuckwell, H. C.; Hanslik, T.; Valleron, A. J.; Flahault, A.  A Mathematical Model for Evaluating the Impact of Vaccination Schedules: Application to Neisseria Meningitidis.  Epidemiol.Infect.  130 (3): 419-429; June 2003.

  59. Uzonna, J. E.; Chilton, P.; Whitlock, R. H.; Habecker, P. L.; Scott, P.; Sweeney, R. W.  Efficacy of Commercial and Field-Strain Mycobacterium Paratuberculosis Vaccinations With Recombinant IL-12 in a Bovine Experimental Infection Model.  Vaccine.  21 (23): 3101-3109; July 4, 2003.

  60. Vazquez, S.; Valdes, O.; Pupo, M.; Delgado, I.; Alvarez, M.; Pelegrino, J. L.; Guzman, M. G.  MAC-ELISA and ELISA Inhibition Methods for Detection of Antibodies After Yellow Fever Vaccination.  J Virol.Methods.  110 (2): 179-184; June 2003.

  61. Vynnycky, E.; Gay, N. J.; Cutts, F. T.  The Predicted Impact of Private Sector MMR Vaccination on the Burden of Congenital Rubella Syndrome.  Vaccine.  21 (21-22): 2708-2719; June 20, 2003.

  62. Wagner, C.; Popp, W.; Posch, M.; Vlasich, C.; Rosenberger-Spitzy, A.  Impact of Pneumococcal Vaccination on Morbidity and Mortality of Geriatric Patients: a Case-Controlled Study.  Gerontology.  49 (4): 246-250; July 2003.

  63. Wathne, K. O.; Fjaerli, H. O.; Flaegstad, T.; Abrahamsen, T. G.  [More Children Should Be Vaccinated Against Pneumococcal Disease].  Tidsskr.Nor Laegeforen.  123 (9): 1198-1200; May 1, 2003.

  64. Yih, W. K.; Lieu, T. A.; Rego, V. H.; O'Brien, M. A.; Shay, D. K.; Yokoe, D. S.; Platt, R.  Attitudes of Healthcare Workers in U.S. Hospitals Regarding Smallpox Vaccination.  BMC.Public Health.  3 (1): 20; June 11, 2003.

  65. Zuckerman, J. N.  Vaccination Priorities in Travel.  BioDrugs.  17 (Suppl. 1) :1-6; 2003.

Back to Top